Thorsten Klampfl
Impact in
- Genetics top 1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
- Genetics 14
- Myeloproliferative Neoplasms: Diagnosis and Treatment 9
- Chronic Lymphocytic Leukemia Research 5
- Hematology 12
- Acute Myeloid Leukemia Research 8
- Chronic Myeloid Leukemia Treatments 6
- Co-authors
- Róbert Královics (9 shared papers)Ashot S. Harutyunyan (7 shared papers)Elisa Rumi (7 shared papers)Daniela Pietra (7 shared papers)Mario Cazzola (7 shared papers)Tiina Berg (6 shared papers)Chiara Elena (3 shared papers)Jelena D. Milosevic Feenstra (2 shared papers)
In The Last Decade
Thorsten Klampfl
19 papers receiving 1.1k citations
Thorsten Klampfl's Hit Papers
Peers
Comparison fields: 5 of 71
- Genetics 682
- Hematology 528
- Rheumatology 211
- Molecular Biology 634
- Cancer Research 109
Countries citing papers authored by Thorsten Klampfl
This map shows the geographic impact of Thorsten Klampfl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thorsten Klampfl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thorsten Klampfl more than expected).
Fields of papers citing papers by Thorsten Klampfl
This network shows the impact of papers produced by Thorsten Klampfl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thorsten Klampfl. The network helps show where Thorsten Klampfl may publish in the future.
Co-authors
The 25 scholars most cited alongside Thorsten Klampfl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes Hit paper breakdown → | 2013 | 396 |
| 2 | 2014 | 129 | |
| 3 | 2011 | 128 | |
| 4 | 2010 | 105 | |
| 5 | 2011 | 80 | |
| 6 | 2011 | 78 | |
| 7 | 2017 | 60 | |
| 8 | 2011 | 31 | |
| 9 | 2011 | 29 | |
| 10 | 2020 | 28 | |
| 11 | 2021 | 27 | |
| 12 | 2022 | 10 | |
| 13 | 2009 | 9 | |
| 14 | 2024 | 8 | |
| 15 | 2023 | 6 | |
| 16 | 2024 | 4 | |
| 17 | 2017 | 4 | |
| 18 | 2010 | 3 | |
| 19 | 2025 | 3 | |
| 20 | 2024 | 0 |
About Thorsten Klampfl
Thorsten Klampfl is a scholar working on Genetics, Hematology, Molecular Biology, Immunology and Pathology and Forensic Medicine, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Acute Myeloid Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Kruppel-like factors research (4 papers), Immune Cell Function and Interaction (4 papers), Acute Lymphoblastic Leukemia research (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Genetics (682 citations), Hematology (528 citations), Rheumatology (211 citations), Molecular Biology (634 citations) and Cancer Research (109 citations). Thorsten Klampfl has collaborated with scholars based in Austria, Italy and Germany. Frequent co-authors include Róbert Královics, Ashot S. Harutyunyan, Elisa Rumi, Daniela Pietra, Mario Cazzola, Tiina Berg, Chiara Elena, Jelena D. Milosevic Feenstra, Cristiana Pascutto and Ilaria Carola Casetti. Their work appears in journals such as Blood, American Journal of Hematology, iScience, Experimental Hematology and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.